The 2nd Princess Chulabhorn Award Presentation Ceremony
Professor Dr. Her Royal Highness Princess Chulabhorn Krom Phra Srisavangavadhana presided over the 2nd Princess Chulabhorn Award Presentation Ceremony for the 2024 Award, held on 18 July 2025 at Grand Ballroom A, 4th Floor, Asawin Grand Convention Hotel.
Professor Dennis J. Slamon, MD, PhD, an American medical oncologist from the University of California, Los Angeles
(UCLA), United States of America. He is renowned for his discovery of the Human Epidermal Growth Factor Receptor 2
(HER2) gene, which led to the development of Trastuzumab, a biologic targeted therapy that revolutionized cancer treatment.
On this occasion, Professor Slamon delivered a special lecture on his contributions to cancer research entitled “Identification
& Validation of Novel Targets in Oncology: From HER2 to the CDK-4/6 Kinases: Biologic and Therapeutic Implications.”
Photographs of the 2nd Princess Chulabhorn Award Presentation Ceremony
Reception in Honour of the Princess Chulabhorn Award Recipient
Following the Award Presentation Ceremony, the Foundation hosted a reception in honour of the Award recipient. During the reception, Emeritus Professor Dr. Rajata Rajatanavin delivered congratulatory remarks to Professor Dennis J. Slamon.
Photographs of the reception in Honour of the Princess Chulabhorn Award Recipients
The Interview following the Award Presentation Ceremony
The Award Presentation Ceremony concluded with an interview session featuring Professor Dennis J. Slamon and members of the Princess Chulabhorn Award Foundation Committee, moderated by Capt. Dr. Yongyuth Mayalarp. The interviews covered several topics, including Professor Slamon’s reflections on receiving the Princess Chulabhorn Award, his most notable achievements, his contributions to advancing cancer research and their impact on humanity, as well as his current work and its implications for society and global health.
Photographs of the interview